Skip to content

Whole-Body Hypothermia for Neonates With Hypoxic-Ischemic Encephalopathy(HIE)

Modified Whole-Body Hypothermia for Neonates With Hypoxic-Ischemic Encephalopathy

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05581927
Enrollment
0
Registered
2022-10-17
Start date
2022-10-01
Completion date
2024-12-31
Last updated
2023-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injury, Hypoxic- Ischemic Encephalopathy, Whole-Body Hypothermia

Brief summary

Among term infants, hypoxic-ischemic encephalopathy due to acute perinatal asphyxia remains an important cause of brain injury in childhood. Infants with moderate encephalopathy have a 10 percent risk of death, and those who survive have a 30 percent risk of disabilities. Sixty percent of infants with severe encephalopathy die, and many, if not all, survivors are disabled. Whole-body hypothermia reduces the risk of death or disability in infants with moderate or severe hypoxic-ischemic encephalopathy.

Detailed description

Reductions in brain temperature by 2°C to 5°C provide neuroprotection in newborn and adult animal models of brain ischemia.Brain cooling has a favorable effect on multiple pathways contributing to brain injury, including excitatory amino acids, the cerebral energy state, cerebral blood flow and metabolism, nitric oxide production, and apoptosis. Brain cooling is effective in reducing the extent of brain injury even when it is initiated up to 5.5 hours after brain ischemia in near-term sheep fetuses.But, epidemiological data showed that, in non-developed countries and areas,Whole-body hypothermia is related to the increased mortality and brain injury. The cause is unclear.

Interventions

DEVICEmodified Whole-Body Hypothermia

patients were allocated to modified Whole-Body Hypothermia with normal base excess and blood pressure

DEVICEstandard Whole-Body Hypothermia

patients were allocated to standard Whole-Body Hypothermia

Sponsors

Children's Hospital of Chongqing Medical University
CollaboratorOTHER
Children's Hospital of Suzhou
CollaboratorUNKNOWN
Women and Children's Hospital of Chongqing
CollaboratorUNKNOWN
Women and Children's Hospital of Guangxi
CollaboratorUNKNOWN
People's hospital of Guangyuan
CollaboratorUNKNOWN
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

one group was allocated to standard Whole-Body Hypothermia, another group was allocated to modified Whole-Body Hypothermia

Eligibility

Sex/Gender
ALL
Age
0 Hours to 24 Hours
Healthy volunteers
No

Inclusion criteria

* pH of 7.0 or less or a base deficit of 16 mmol per liter or more in a sample of umbilical cord blood or any blood during the first hour after birth. If, during this interval,a pH was between 7.01 and 7.15, a base deficit was between 10 and 15.9 mmol per liter. or a blood gas was not available, additional criteria were required. These included an acute perinatal event (e.g., late or variable decelerations, cord prolapse, cord rupture,uterine rupture, maternal trauma, hemorrhage, or cardiorespiratory arrest) and either a 10-minute Apgar score of 5 or less or assisted ventilation initiated at birth and continued for at least 10 minutes. * equal to or more than 36 weeks

Exclusion criteria

* congenital malformation * parents' refusal

Design outcomes

Primary

MeasureTime frameDescription
death30 daysneonates are dead during hospital
brain injury30 daysneonates are diagnosed with brain injury

Secondary

MeasureTime frameDescription
the incidence of intraventricular hemorrhage2-3 weekintraventricular hemorrhage was diagnosed
the incidence of suspend of Whole-Body Hypothermiawithin 3 daysWhole-Body Hypothermia is suspended
neurodevelopmental assessmentone monthneurodevelopment is assessed using NBNA
the incidence of periventricular leukomalaciawithin 30 daysPeriventricular leukomalacia is diagnosed
the incidence of discharge according to the doctor's suggestion2-3 weeksneonates were discharged according to the doctor's suggestion

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026